ONLY HEALTHCARE

ONLY HEALTHCARE FEATURING MICHAEL NAVIN & DR. RANDY VOGENBERG
  • 5.0 (6)
  • BUSINESS
  • UPDATED BIMONTHLY

The “Only Healthcare” podcast reveals shocking truths about the healthcare industry. Why are US Healthcare costs and risks so high? How will new technologies impact the system? What are the challenges in accessing new therapies and treatments? What is happening with Big Pharma and how do they influence other stakeholders in healthcare? Hosted by industry experts Michael Navin and Dr. Randy Vogenberg, to provide you with actionable and inspirational insights on how we can improve healthcare cost, care and accessibility for all. Hosted by:Michael Navin & Dr. Randy VogenbergMichael's LinkedInhttps://www.linkedin.com/in/michael-navin-7411388/Randy's LinkedInhttps://www.linkedin.com/in/randyvogenberg/Sponsored by:Only Healthcare is sponsored by Peek and the Institute for Integrated Health. Peek: Peek is reimagining access through innovation, technology, connectivity, and partnership. Peek offers a comprehensive and unique suite of solutions to help clients improve access and affordability for prescription drugs. The Peek Meds Marketplace is one of Peek’s differentiated offerings that gives employers a revolutionary new approach to controlling runaway prescription costs for their employees by providing unprecedented transparency, simplicity - and cost savings. The Peek Meds Marketplace aggregates cash discount cards, manufacturer copay offset programs, and an employee’s insurance information to provide a holistic and personalized view of prescription price options. This easy-to-use platform offers a one-stop-shopping experience for prescription drugs.Peek’s team has decades of experience in the pharmaceutical industry and offers various services to biopharma manufacturers, brokers, benefits consultants, third-party administrators and employers. Visit peekmeds.com to learn more. Institute for Integrated Health (IIH):Healthcare benefits, insurance coverage regulations, and business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provide strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning, and advisory on market trends and U.S. healthcare market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. Learn more by visiting https://iih-online.com/. Music by:Hanu Dixit, https://www.youtube.com/hanudixitDisclaimer:© 2025 Only Healthcare Podcast. All rights reserved. This podcast and its content, including but not limited to audio recordings, images, and text, are the property of the Only Healthcare Podcast and are protected by international copyright laws. We appreciate all distribution and content sharing. Contact us at onlyhealthcarepodcast@gmail.com to access our media kits, provide feedback or inquire about guest participation. Thank you for listening. 

  1. EP 42 | GLP-1s Explained: Breakthrough Therapy, Budget Disruptor, or Both?

    7H AGO

    EP 42 | GLP-1s Explained: Breakthrough Therapy, Budget Disruptor, or Both?

    GLP-1 medications have moved from diabetes treatment to a cultural phenomenon in record time. But beyond the headlines and celebrity endorsements lies a far more complex story. In Episode 42, Dr. Randy Vogenberg breaks down what GLP-1s actually are, how they function in the body, and why they are reshaping conversations around obesity, metabolic syndrome, cardiovascular risk, and employer health plan budgets. From Ozempic and Wegovy to emerging alternatives, this episode explores the clinical promise, the side effects, and the financial shockwaves hitting plan sponsors across the country. For pharmaceutical leaders, HR executives, consultants, and policy stakeholders, this conversation goes beyond weight loss. It addresses what happens when innovation outpaces coverage strategy and how benefit decision makers are responding to one of the most disruptive drug classes in recent history. Key Topics What GLP-1 medications are and how they workThe science behind metabolic syndrome and weight regulationGLP-1s vs. SGLT2 inhibitorsFrom diabetes treatment to weight loss demandGLP-1s as an alternative to bariatric surgeryCardiovascular and metabolic benefitsSide effects and risk considerationsEmployer and government plan coverage challengesBudget impact and utilization explosionLong-term implications for benefit design and market access Episode Chapters with Timestamps 00:00 – Introduction to Healthcare 101: GLP-1s 00:32 – What are GLP-1 medications? 01:01 – How GLP-1s affect appetite, digestion, and blood sugar 02:48 – Understanding metabolic syndrome 04:20 – Lifestyle factors vs. pharmaceutical intervention 05:30 – GLP-1s vs. SGLT2 inhibitors 06:45 – From bariatric surgery to pharmaceutical alternative 07:56 – Plan sponsor perspective and coverage disruption 09:13 – Who qualifies and why coverage changed 09:27 – Side effects and real world risks 10:52 – Cardiovascular approvals and expanded indications 11:59 – Type 1 vs. Type 2 diabetes management 13:46 – Final thoughts on the future of GLP-1s Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    15 min
  2. Ep 41 | Healthcare 101: Who Really Controls Cost, Access, and Coverage?

    FEB 19

    Ep 41 | Healthcare 101: Who Really Controls Cost, Access, and Coverage?

    In this inaugural Healthcare 101 segment, Dr. Randy Vogenberg breaks down the fundamentals of the American health insurance system. From the evolution of employer-sponsored coverage to the rise of managed care and vertical integration, this episode explores why healthcare feels so complex and where the money actually flows. Listeners will gain clarity on the role of middlemen, cost shifting, site of care decisions, and what individuals can do to better navigate the system. Whether you are an employer, industry leader, or consumer, this episode offers foundational insights to help you make more informed healthcare decisions. Key Topics The historical evolution of the American health insurance systemCost, access, and quality as the core healthcare triangleEmployer-sponsored coverage and government programsThe rise of managed care and third-party intermediariesVertical integration and consolidation in healthcareWho the “middlemen” are and how they influence costsTransparency challenges in healthcare pricingCash pay options vs. traditional insurance pathwaysHow consumers and employers can become more engaged Episode Chapters with Timestamps 00:00 – Introduction to Healthcare 101 00:34 – What is the American health insurance system? 01:04 – How cost, access, and quality shape healthcare 03:55 – Why the system is so complicated 05:20 – Who are the key players in healthcare? 07:15 – The role of middlemen and consolidation 09:16 – Vertical integration explained 09:59 – What individuals can do to navigate the system 11:51 – Cash pricing vs. traditional insurance models 13:00 – Why understanding the system matters Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    14 min
  3. Ep 40 | Engaging the Healthcare Consumer: Transparency, Trust, and the Skills We Are Missing

    FEB 12

    Ep 40 | Engaging the Healthcare Consumer: Transparency, Trust, and the Skills We Are Missing

    In this episode of the Only Healthcare Podcast, Michael Navin and Randy Vogenberg welcome Lynn Hanessian, founder of Engager, for a wide-ranging discussion on why healthcare engagement has become a critical challenge for employers, providers, and consumers. Drawing on her background in economics, healthcare communications, and strategy, Lynn explains how rising costs, shifting information sources, and complex benefit designs are placing new demands on patients who are not equipped to navigate them. The conversation explores transparency, trust, technology, AI, employer responsibility, and the growing need to teach consumers how to engage with healthcare decisions in real time. Key Topics Discussed • Why healthcare engagement has become a missing skill • The shift of cost and decision-making to patients • How employers have become the most trusted healthcare messenger • Transparency gaps in pricing and plan design • Changing information behaviors and the rise of generative search • AI, technology, and their limits in improving care today • Consumer confusion around access, urgency, and cost • Public trust, misinformation, and the burden on providers • What engagement must look like for the future of care Episode Chapters with Time-Stamps 00:05 – Welcome and introduction 01:05 – Lynn Hannessian’s background and focus on engagement 03:32 – Defining engagement and identifying critical audiences 05:06 – Employers, patients, and the information gap 06:12 – Shifts in how people seek healthcare information 09:22 – Care management, stakeholders, and alignment challenges 12:13 – Transparency tools and pricing visibility 15:06 – Empowering consumers to question costs 16:07 – Building healthcare literacy and decision skills 18:02 – Trust, misinformation, and public health messaging 21:10 – AI, post-COVID acceleration, and system strain 24:58 – Access challenges in rural and underserved areas 26:37 – Expectations of consumers and providers 29:41 – Policy, JPMorgan conference insights, and what is coming 34:25 – Specialty care growth and employer readiness 36:11 – Multi-generational care complexity 37:51 – Closing thoughts and where engagement goes next Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    38 min
  4. Ep 39 | The Great American Healthcare Heist: Transparency, Power, and What Must Change

    FEB 5

    Ep 39 | The Great American Healthcare Heist: Transparency, Power, and What Must Change

    In this episode of the Only Healthcare Podcast, Michael Navin and Randy Vogenberg welcome healthcare attorney, policy advocate, and author Chris Deacon for an in-depth conversation on how structural incentives, middlemen, and lack of transparency have reshaped the U.S. healthcare system. Drawing from her experience overseeing New Jersey’s state health benefits program and her book The Great American Healthcare Heist, Chris explains how employers and public sector plans are increasingly squeezed by rising costs, opaque pharmacy benefit structures, hospital consolidation, and technology deployed to optimize revenue rather than reduce spend. The episode explores why understanding contracts, data, and incentives is critical and where real opportunities for reform may still exist. Key Topics Discussed • How healthcare incentives became misaligned across the system • Why transparency is essential to restoring affordability • The evolving role and impact of pharmacy benefit managers • FDA approval, drug marketing, and assumptions about efficacy • Vertical integration and the corporatization of medicine • Public sector healthcare insolvency and budget crowd-out • How AI is being used to optimize billing rather than reduce costs • Practical levers employers can use to regain control Episode Chapters with Time-Stamps 00:04 – Welcome and introduction to Chris Deacon 01:01 – Chris’s background in public service and healthcare oversight 03:12 – Why state healthcare plans mirror the commercial market 04:16 – The motivation behind The Great American Healthcare Heist 07:28 – Training gaps and healthcare literacy challenges 09:07 – Pharmacy benefits, PBMs, and middlemen dynamics 12:21 – FDA approval, drug marketing, and flawed assumptions 14:49 – Healthcare spending surpasses $5 trillion 16:04 – Public sector insolvency and budget crowd-out 18:54 – AI, revenue optimization, and unintended consequences 20:17 – Hospital consolidation and vertical integration 23:20 – Transparency, direct contracting, and paths forward 26:22 – Practical levers employers can pull today 29:19 – Early signs of market change 31:27 – Closing reflections and call to action Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    33 min
  5. Ep 38 | Rethinking Risk: How Employers Prepare for Cell and Gene Therapy

    JAN 29

    Ep 38 | Rethinking Risk: How Employers Prepare for Cell and Gene Therapy

    In this episode of the Only Healthcare Podcast, hosts Michael Navin and Randy Vogenberg are joined by Luke Prettol, benefits strategy leader at AT&T, for a deep dive into how employers are preparing for the growing impact of cell and gene therapies. The conversation focuses less on headline costs and more on the real risk employers face as utilization increases, therapies evolve, and benefit design struggles to keep pace. Luke explains how AT&T defines success in benefits strategy, prioritizing patient outcomes while staying ahead of market trend. He walks through how large employers think about claim size, long-term value, and the growing complexity tied to treatment risk, provider selection, and fair pricing. The episode explores why rare disease therapies will no longer be one-off events, how proactive patient identification and centers of excellence can reduce risk, and why employers must plan several years ahead instead of reacting year to year. Key Topics Discussed • How employers define success beyond lowest cost • Why cell and gene therapies create new risk challenges • Treatment risk, provider risk, and financial risk explained • Why rare diseases are becoming more common at scale • Planning for 3–7 year benefit strategy horizons • Proactive patient identification and care navigation • Centers of excellence and site-of-care decisions • Managing pricing certainty and outcome accountability • Budget volatility, stop-loss pressure, and financial risk • Structural challenges including ERISA erosion and data gaps Episode Chapters & Timestamps 00:04 Welcome and episode overview 01:36 Luke Prettol background and role at AT&T 02:21 How employers define winning in benefits strategy 03:30 Claim size versus outcomes and long-term value 06:45 The three core risks employers must manage 08:30 Why cell and gene therapies change the risk equation 10:34 Rare disease growth and planning for 2030 13:19 Lessons from specialty drug adoption 15:24 Proactive patient identification and early intervention 19:50 Centers of excellence and treatment accuracy 22:03 Predictability, data, and risk reduction 23:26 ROI, retention, and member experience 26:22 The employer “triple pain” framework 32:35 Defining success and planning beyond today 36:06 Closing remarks Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    37 min
  6. Ep 37 | Why Employers Are Reinvesting in Primary Care and What It Means for Cost, Care, and Engagement

    JAN 22

    Ep 37 | Why Employers Are Reinvesting in Primary Care and What It Means for Cost, Care, and Engagement

    Employers are no longer waiting for healthcare costs to stabilize. In this episode, Randy Vogenberg and Michael Navin are joined by Murray Harbour to break down why advanced primary care, direct contracting, and value-based benefit design are moving from pilot ideas to core employer strategies. The conversation examines how employers are shifting away from traditional networks, why prevention and engagement continue to struggle at scale, and what is finally changing in 2025 and beyond. From GLP-1 program missteps to bundled care models and local primary care solutions, this episode offers real-world examples of how employers can regain control of cost while improving access and outcomes. Key Topics Discussed Why employer healthcare renewals are driving new benefit strategiesThe difference between direct primary care and advanced primary care modelsEvidence behind primary care investment and long-term cost controlWhy ROI is giving way to the value of investment in benefits planningEmployer frustration with access, billing complexity, and care delaysHow self-funded employers are bypassing traditional networksWhat GLP-1s revealed about program design and wraparound carePBM contract limitations and emerging workaroundsThe growing role of local, high-touch primary care modelsWhat benefit planning for 2026 and 2027 is starting to look like Episode Chapters and Timestamps 00:00 Welcome and guest introduction 01:40 What is changing for employers post-pandemic 02:40 Does primary care investment actually lower costs 03:45 ROI versus value of investment in benefits 04:40 Prevention, wellness, and engagement challenges 05:55 Direct vs advanced primary care explained 06:55 Why employers are bypassing traditional networks 08:10 Provider systems adopting advanced primary care 09:50 Why benefits moved down and back up the priority list 11:05 Legislative incentives and misalignment 13:20 What employers are planning for 2026 14:55 PBM contracts and pharmacy control 16:50 Multi-generational benefits and engagement 18:00 How younger workers are reshaping benefit expectations 21:05 Why change happens slowly and strategically 24:15 The future of advanced primary care and local models 27:45 Primary care as the quarterback of care 28:40 Closing thoughts and wrap-up Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    30 min
  7. Ep 36 | Drug Pricing at the Center: IRA, MFN, and Employer Direct Purchasing in 2026

    JAN 15

    Ep 36 | Drug Pricing at the Center: IRA, MFN, and Employer Direct Purchasing in 2026

    In this episode of the Only Healthcare Podcast, hosts Michael Navin and Dr. Randy Vogenberg welcome back Jayson Slotnick for a fast-moving year-in-review of 2025 and a grounded outlook for 2026. The conversation breaks down what changed through the Inflation Reduction Act implementation, why Most Favored Nation pricing keeps resurfacing, and how these policy forces could ripple across Medicare, Medicaid, and employer-sponsored coverage.  Jayson also explores how direct purchasing, transparent pricing models, and the shifting PBM landscape may affect affordability, access, and benefit design. From Part D redesign and underused smoothing to biosimilars, 340B dynamics, and the role of the FDA in driving competition, this episode connects the policy headlines to what employers, manufacturers, and plans should realistically watch next. Key Topics • 2025 recap: IRA implementation and Part D redesign • Drug negotiation timelines and spillover effects • Most Favored Nation pricing: what is voluntary vs mandatory • Patient affordability: premiums, deductibles, out-of-pocket pressure • Employer direct purchasing, net pricing, and PBM disruption • Biosimilars, patent cliffs, and what 2027 could change • 340B, hospital economics, and who really benefits from drug money • FDA’s role: faster approvals, competition, and innovation • 2026 watchlist: Part B negotiation list, CMS rules, ACA dynamics, CMMI models Chapters 00:04 Welcome and intro to Jayson Slotnick 02:04 2025 recap: IRA, CMS, affordability pressures 02:45 Predictable vs unpredictable: Part D redesign, MFN momentum 06:22 IRA vs MFN: separate lanes, real-world collisions 09:12 Voluntary MFN models, IRA is not voluntary 12:24 Employer net pricing and direct purchasing trends 16:30 Affordability, hospital costs, and 340B dynamics 18:57 FDA’s role: competition, generics, biosimilars, faster approvals 23:22 2026 predictions: what we know is coming 29:06 Stay current, stay calm, stay focused 31:51 Commercial market changes and employer leverage 39:33 Wrap and where to follow OHP Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    40 min
  8. Ep 35 | Healthcare at a Breaking Point: Costs, Policy Gridlock, and What 2026 Holds

    JAN 8

    Ep 35 | Healthcare at a Breaking Point: Costs, Policy Gridlock, and What 2026 Holds

    In this episode of the Only Healthcare Podcast, hosts Michael Navin and Randy Vogenberg welcome back healthcare policy veteran Deborah Williams for a candid conversation on why 2025 became such a difficult year for employers, patients, and policymakers alike. Coming off the tensions of the government shutdown and escalating healthcare costs, the discussion breaks down what is actually driving premium increases, prescription drug spending, hospital consolidation, and benefit design changes. Deborah draws on decades of Washington experience to explain why many policy ideas keep resurfacing, why they continue to fall short, and what risks lie ahead as the system moves into 2026. From direct-to-consumer drug pricing and PBM reform to political gridlock and consumer backlash, this episode explores where healthcare policy may realistically land next and why affordability remains the unanswered question. Key Topics Discussed Why employer healthcare costs outpaced exchange inflation in 2025Hospital consolidation and cost-shifting pressuresPrescription drug spending trends and policy spillover effectsDirect-to-consumer drug pricing and deductible portabilityPBM reform debates and unintended consequencesPolitical gridlock, populism, and healthcare affordabilityWhat employers, plans, and consumers may face in 2026 Chapters with Time Stamps 00:04 Welcome and episode framing 00:44 Deborah Williams' background and policy perspective 01:44 Why 2025 was a brutal year for employers 03:34 Hospital consolidation and cost shifting 04:35 Prescription drug costs and market pressure 07:15 Consumer behavior, adherence, and affordability 09:00 Political realities and exchange subsidies 12:08 Insurers, public sentiment, and misinformation 14:03 Drug pricing models and global comparisons 16:41 Employer leverage and failed market solutions 17:49 Emerging therapies and future cost risk 20:24 What could improve in 2026 24:26 Populism and the next policy inflection point Michael's LinkedIn Randy's LinkedIn Sponsored by: Peek: A game-changing prescription shopping solution that allows its members to view all their prescription cost options across cash discount programs and their insurance in one easy-to-use platform. Peek is currently being offered to organizations to help both employees and plan sponsors save money on their prescription spend. https://peekmeds.com/. Institute for Integrated Health (IIH): Health care benefits, insurance coverage regulations, and doing business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provides strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning and advisory on market trends, and U.S. health care market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. https://iih-online.com/.

    26 min
See All (42)

Ratings & Reviews

5
out of 5
6 Ratings

About

The “Only Healthcare” podcast reveals shocking truths about the healthcare industry. Why are US Healthcare costs and risks so high? How will new technologies impact the system? What are the challenges in accessing new therapies and treatments? What is happening with Big Pharma and how do they influence other stakeholders in healthcare? Hosted by industry experts Michael Navin and Dr. Randy Vogenberg, to provide you with actionable and inspirational insights on how we can improve healthcare cost, care and accessibility for all. Hosted by:Michael Navin & Dr. Randy VogenbergMichael's LinkedInhttps://www.linkedin.com/in/michael-navin-7411388/Randy's LinkedInhttps://www.linkedin.com/in/randyvogenberg/Sponsored by:Only Healthcare is sponsored by Peek and the Institute for Integrated Health. Peek: Peek is reimagining access through innovation, technology, connectivity, and partnership. Peek offers a comprehensive and unique suite of solutions to help clients improve access and affordability for prescription drugs. The Peek Meds Marketplace is one of Peek’s differentiated offerings that gives employers a revolutionary new approach to controlling runaway prescription costs for their employees by providing unprecedented transparency, simplicity - and cost savings. The Peek Meds Marketplace aggregates cash discount cards, manufacturer copay offset programs, and an employee’s insurance information to provide a holistic and personalized view of prescription price options. This easy-to-use platform offers a one-stop-shopping experience for prescription drugs.Peek’s team has decades of experience in the pharmaceutical industry and offers various services to biopharma manufacturers, brokers, benefits consultants, third-party administrators and employers. Visit peekmeds.com to learn more. Institute for Integrated Health (IIH):Healthcare benefits, insurance coverage regulations, and business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provide strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning, and advisory on market trends and U.S. healthcare market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. Learn more by visiting https://iih-online.com/. Music by:Hanu Dixit, https://www.youtube.com/hanudixitDisclaimer:© 2025 Only Healthcare Podcast. All rights reserved. This podcast and its content, including but not limited to audio recordings, images, and text, are the property of the Only Healthcare Podcast and are protected by international copyright laws. We appreciate all distribution and content sharing. Contact us at onlyhealthcarepodcast@gmail.com to access our media kits, provide feedback or inquire about guest participation. Thank you for listening. 

Information

  • Creator
    ONLY HEALTHCARE FEATURING MICHAEL NAVIN & DR. RANDY VOGENBERG
  • Years Active
    2024 - 2026
  • Episodes
    42
  • Rating
    Clean
  • Copyright
    © 2026 ONLY HEALTHCARE
  • Show Website
    ONLY HEALTHCARE